Cofounder and Executive Chairman Dr. Steve Sun grew GENEWIZ, a leading global genomics service provider, from a two-person biotech startup to an international operation employing more than 1,000 people across 12 facilities around the world. GENEWIZ was acquired in September for $450 million.
Sun will share his GENEWIZ story, followed by a Q&A.
5:30–6:00 p.m., Networking
6:00 p.m., Fireside Chat